Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells
Meng‐Tzu Weng(National Institutes of Health), Ji Luo(Central South University), Giuseppe Giaccone(Cornell University), Christina M. Annunziata(National Cancer Institute), Stephen Swatkoski(National Institutes of Health), Shu‐Chen Wei(Kaohsiung Medical University), Susan H. Garfield(National Institutes of Health), Chad J. Creighton(Baylor College of Medicine), Curtis C. Harris(National Cancer Institute), Sina Shahamatdar(National Institutes of Health), Jih‐Hsiang Lee(National Cancer Institute), Michael J. Emanuele(University of North Carolina at Chapel Hill), Qiuning Li(National Institutes of Health), Dennis Hsu(University of Pittsburgh Medical Center), Poonam Mannan(National Institutes of Health), Marianne K. H. Kim(National Institutes of Health), Marjan Guček(National Heart Lung and Blood Institute), Aaron J. Schetter(AstraZeneca (Singapore)), Jin‐Chuan Sheu(National Taiwan University Hospital)
Cited by 72
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
|Journal of Clinical Oncology|2004|1.7k